SmartZyme spin-off Carnot teams up with HemoShear
Executive Summary
SmartZyme BioPharma Inc. has spun off its protein engineering platform into a new company named Carnot BioSciences LLC to collaborate with HemoShear Therapeutics LLC on the development of protein-based therapies for rare metabolic diseases.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Drug Discovery Tools
- ADMET
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- R&D (No Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice